Business Context and Reporting Period
Company: Processa Pharmaceuticals, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 17, 2022
Event: Regulation FD Disclosure regarding participation in the Oppenheimer 32nd Annual Healthcare Conference.
Financial Metrics
This filing does not contain specific financial data. The document serves as a notice of an upcoming investor presentation and does not report revenue, profit, cash flow, margins, debt, or liquidity figures.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing solely announces the company's scheduled participation in virtual meetings with analysts and investors.
Guidance, Outlook, and Management Commentary
- Event Details: Management will present at the Oppenheimer 32nd Annual Healthcare Conference on March 17, 2022.
- Disclosure Method: The presentation is furnished as Exhibit 99.1 and will be available on the company's website under the "Investors" section.
- Forward-Looking Statements: The company explicitly states it undertakes no duty or obligation to publicly update or revise the information contained in this report or the associated presentation.
- Regulation FD: The company notes it routinely uses its website to disclose material non-public information.
Key Facts for Investor Verification
- Verify the content of the "March 2022 Corporate Presentation" (Exhibit 99.1) for specific business updates, as the 8-K text itself contains no operational details.
- Confirm the presentation is accessible via the company's official website at processapharmaceuticals.com.
- Note that the information in this filing is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.